Dr Vasum Peiris Appointed as Chief Medical Officer
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Dr Peiris brings extensive experience from his previous role at the FDA, where he focused on medical device regulation and innovation. His appointment aims to strengthen EchoIQ's medical leadership and support the adoption of its AI-powered technologies in the US healthcare market. CEO Dustin Haines emphasized that Dr Peiris's expertise will be crucial for advancing the company's regulatory strategy and commercial growth.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from EchoIQ
- Notification regarding unquoted securities - EIQ
- Quarterly Activities Report & Appendix 4C Cashflow Report
- Notice of Annual General Meeting/Proxy Form
- Notification of cessation of securities - EIQ
- EchoSolv HF FDA 510(k) update
Later from EchoIQ
- Bell Potter Healthcare Conference Presentation
- Pause in Trading
- Trading Halt
- EchoSolv HF regulatory update
- Application for quotation of securities - EIQ
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ